Antileishmanial activity of the estrogen receptor modulator raloxifene.
BACKGROUND: The treatment of leishmaniasis relies mostly on parenteral drugs with potentially serious adverse effects. Additionally, parasite resistance in the treatment of leishmaniasis has been demonstrated for the majority of drugs available, making the search for more effective and less toxic dr...
Main Authors: | Juliana Q Reimão, Danilo C Miguel, Noemi N Taniwaki, Cristiana T Trinconi, Jenicer K U Yokoyama-Yasunaka, Silvia R B Uliana |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4014391?pdf=render |
Similar Items
-
Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice.
by: Danilo C Miguel, et al.
Published: (2008-01-01) -
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
by: Juliana Q Reimão, et al.
Published: (2015-02-01) -
Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in Aβ-Oligomer-Induced Neuronal Injury
by: Tetsuhito Nohara, et al.
Published: (2023-07-01) -
The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice
by: Danilo Ciccone Miguel, et al.
Published: (2010-11-01) -
Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)